Europe Artificial Organs and Bionics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Artificial organs and bionics are manufactured devices that can be embedded or integrated into humans to either replace a natural organ or offer support to repair specific function, helping the patient return back to healthy living.

Europe Artificial Organ and Bionics Market Size and Growth:

Europe artificial organ and bionics market reaches nearly $XX billion by 2025 at a CAGR of 11.42% during the forecast period 2019-2025. Rising number of organ failures and disabilities, increasing technological advancements, and increasing of road accidents are bolstering the artificial organs and bionics market growth. Increasing number of device malfunctions and lack of skilled professionals are hindering the market growth.

Europe Artificial Organ and Bionics Market Segments Share:

Europe artificial organs and bionics market is segmented by a product such as an artificial organ and bionics. An artificial kidney, artificial heart and artificial liver are considered under the artificial organ. Vision bionics, orthopaedic bionics, cardiac bionics and brain bionics are considered under the bionics. By technology, the electronic bionics is an electronic device which is used in various applications such as defence sector in exoskeleton suits which helps the soldier to carry heavy loads in the battlefield which are likely to have a high emerging growth in the artificial organ and bionics market.

By Geography, Germany occupied the lion’s share in the European artificial organs and bionics market. Dominant share is accredited due to the vast technological advancements and increasing number of organ failures and injuries. U.K. is the second primary market in Europe artificial organ and bionics market.

Europe Artificial Organ and Bionics Market Segments trends:

• In February 2018, Jikei University of medicine made an agreement with Asahi Kasei Corporation for an abdominal aortic aneurysm stent development.
• In January 2018, Boston scientific received and FDA approved for spectra wave writer, spinal cord stimulator system.

Europe Artificial Organ and Bionics Market Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year-on-year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary key players are:

• Edward Lifesciences.
• Medtronic
• LifeNet Health Inc.
• Otto Bock Healthcare GmbH.
• Esko Bionics
• Hoffman La Roche Ltd

Along with these companies, there were many other companies considered in the report while analysing the Europe artificial organs and bionics market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.